semaglutide and cardiovascular outcomes in patients with type 2 diabetes align more closely attained dose than achieved weight loss Cardiovascular outcomes of semaglutide and

your time is now

Your healthcare provider will then increase the dose to 5 mg weekly, with potential further increases in 2.5 mg increments every four weeks based on glycemic response and tolerability

In this episode, we break down why recess is not a reward and should never be used as a punishment

What this can look like: observing hormone patterns across cycles identifying ovulation patterns over time comparing cycles before and during GLP-1 use noticing trends, not just single changes Important context: Tracking is observational , not diagnostic Hormonal changes can have multiple causes GLP-1 is one of several factors that may influence patterns The goal is not to explain why but to help you capture whats changing

For prediabetes specifically, focus on eating a healthy diet, working out, and regularly meeting with a healthcare provider

Filardi, T